Valeant Pharmaceuticals to Present at the UBS Global Life Sciences Conference

Share Name	Share Symbol	Market	Type
Valeant Pharmaceuticals International, Inc.	AMEX:VRX	AMEX	Common Stock

Share Name

Share Symbol

Market

Type

Valeant Pharmaceuticals International, Inc.

AMEX:VRX

AMEX

Common Stock

Price Change

% Change

Share Price

High Price

Low Price

Open Price

Shares Traded

Last Trade

0.00

0.00%

Valeant Pharmaceuticals to Present at the UBS Global Life Sciences Conference

17/09/2009 1:00pm

PR Newswire (US)

Valeant Pharmaceuticals International, Inc. (AMEX:VRX)
Historical Stock Chart

From May 2019 to May 2024

Click Here for more Valeant Pharmaceuticals International, Inc. Charts.

ALISO VIEJO, Calif., Sept. 17 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE:VRX) today announced that J. Michael Pearson, the Company's chairman and chief executive officer, will make a presentation at the UBS Global Life Sciences Conference on Wednesday, September 23, 2009 at 1:00 p.m. EDT. The conference will be held at The Grand Hyatt New York in New York City. A live webcast and audio archive will be available on the company's Web site at http://www.valeant.com/. Click on Investor Relations, and then the link to Events and Presentations. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. The webcast also can be accessed through the following URL: http://cc.talkpoint.com/ubsx001/092109a_ke/?entity=136_UGHNC31 About Valeant Valeant Pharmaceuticals International (NYSE:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology and dermatology. More information about Valeant can be found at http://www.valeant.com/. Contact: Laurie Little Valeant Pharmaceuticals 949-461-6002 (Logo: http://www.newscom.com/cgi-bin/prnh/20081125/VALEANTLOGO) http://www.newscom.com/cgi-bin/prnh/20081125/VALEANTLOGO http://photoarchive.ap.org/ DATASOURCE: Valeant Pharmaceuticals International CONTACT: Laurie Little of Valeant Pharmaceuticals, +1-949-461-6002 Web Site: http://www.valeant.com/

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

VRX Valeant Pharmaceuticals International, Inc.